Tag archive for ‘Endocrine system’
Jewish Business News On Tuesday, July 14th, 2015

LabStyle Innovations’ Dario Diabetes Management Solution Now Reimbursed Through a Majority of Medical Plans in Canada

– – Most private insurance plans are now offering reimbursement for the Dario Diabetes Management Solution’s Smart Meter test strips for people who suffer from diabetes, which are produced More...

Gali Weinreb On Wednesday, July 8th, 2015

Biopharma co Chiasma updates Nasdaq IPO terms

  Biopharmaceutical company Chiasma has updated the terms of its Nasdaq IPO with the US Securities and Exchange Commission (SEC). The company, which recently submitted a request for marketing approval More...

Jewish Business News On Tuesday, June 16th, 2015

Israel’s Oramed Granted Patent in Russia for Oral Administration of GLP-1

– – Israeli startup Oramed Pharmaceuticals, a developer of oral drug delivery systems, has been granted by the Russian Federal Service for Intellectual Property a patent for its invention,  More...

Jewish Business News On Saturday, May 23rd, 2015

Faster heart rate linked to diabetes risk

Heart rate measures could identify individuals with a higher future risk of diabetes, according to a four-year study of about 100, 000 Chinese adults. The research found that faster resting heart rates were More...

Jewish Business News On Friday, May 15th, 2015

LabStyle Innovations Receives Health Canada Approval for Commercialization of the Dario

– – Israel’s LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario Diabetes Management Solution, announced that it has been granted Health Canada approval to market and sell More...

Jewish Business News On Friday, February 27th, 2015

Chiasma Raises $70 Million to Advance Its Endocrine Disease Medication

Israeli-American privately held biomed company Chiasma announced the closing of a $70 million Series E financing round. The company will use the new capital to build its sales and marketing capabilities and More...

Jewish Business News On Thursday, February 19th, 2015

Israeli Integrity Applications Signs China Distribution Deal for Glucose Monitoring Device

Israel’s Integrity Applications, the developer of the GlucoTrack model DF-F noninvasive blood glucose measurement device for people who suffer from diabetes, has entered, through its wholly-owned subsidiary, More...

Wordpress site Developed by Fixing WordPress Problems